Skoltech is an international graduate research-focused university that was founded by the group of world-renowned scientists in 2011. Skoltech's curriculum focuses on technology and innovation, offering Master's programs in 11 technological disciplines. Students receive rigorous theoretical and practical training, design their own research projects, participate in internships and gain entrepreneurial skills in English. The faculty is comprised of current researchers with international accreditation and achievements.

American and Japanese Nobel laureates to inaugurate Moscow research centers

PRESS RELEASE

23.04.2014

May 26-28 , 2014

Hypercube, Innovation Center “Skolkovo”, Moscow

International Biomedical Conference “Toward Therapies of the Future” ”

American and Japanese Nobel laureates to inaugurate Moscow research centers

2 Nobel laureates in medicine and leading biomedicine researchers from across the world are slated to get together for an international conference on life saving stem-cell therapies in Moscow on May 26-28.

Participants from Russia, The United States, Holland and Japan will take part in the inaugural “Toward Therapies of the Future” conference and kick-off Skoltech University’s stem cell and bio-medical research centers.

The conference, organized by Skoltech (Skolkovo Institute of Science and Technology), will bring together for the first time in Russia a host of world-renowned experts in bio-medical technology. They will be led by Nobel laureates Philip A Sharp (1993, USA) and Shinya Yamanaka (2012, Japan) who will give keynote speeches and evaluate dozens of Skoltech students’ tech projects. Using poster presentations, the young Russian researchers will have a rare chance to receive recognition from the brightest minds on the planet.

During the conference Skoltech will showcase its recently established centers: Stem Cell Research (led by professor Anton Berns) and Biomedical Technologies and RNA Therapeutics (headed by professor Victor Kotelianski.)

Expert participants will address groundbreaking science which transforms simple skin cells into all-purpose “magic” stem cells. Such stem cells could help treat head and spine injuries, various types of cancer, cardiovascular disease and immune system malfunctions – and ultimately save millions of lives.  Also on the agenda: RNA therapy’s potential for revolutionizing the treatment of complex diseases by “silencing” harmful genes.

Professor Yamanaka pointed out the pressing need for international cooperation: “I hope that many Russian researchers would contribute to the research of Induced Pluripotent Stem Cells (iPS), help develop the technology, and bring iPS cell-bases therapies to the bedside as quickly as possible.”

Among the notable speakers slated to participate are Rudolf Jaenisch (MIT), Rick Young (MIT), Peter Lansdorp (ERIBA institute), and Peter Reddien (MIT).

Background

Skoltech CREIs – Centers for Research Education and Innovation – are partnerships between Russia and international institutions. Established in 2013, the first two centers focus on biomedicine – stem cell research and biomedical technologies and RNA therapy. By 2020, Skoltech aims to create a total of 15 centers. These will address key issues in various tracks – IT, Space, Energy and Nuclear Technology. These should serve as hubs that will attract the best research talent and form cooperation on a global level between the best universities.

The Center for Stem Cell Research was created in collaboration with the Faculty of Medical Sciences at the Institute of General Genetics in the University of Groningen (Netherlands); Vavilov institute Moscow; Hubrecht Institute (the Netherlands); and the Whitehead Institute (MIT, USA).

The Center for Biomedical Technology and RNA Therapy was developed in cooperation with the Moscow State University (MSU) and the Massachusetts Institute of Technology (MIT).

The Skolkovo Institute of Science and Technology (Skoltech) is a non-governmental research university located in Skolkovo (Russia , Moscow region). Created in 2011 as a partnership with the Massachusetts Institute of Technology (MIT), Skoltech aims to forge a new generation of researchers and entrepreneurs, advance scientific knowledge and promote technological innovation to address critical issues facing Russia and the world. The Institute’s work is based on the best traditions of Russian and international education and research practices, with special emphasis on entrepreneurship and innovation.

For more details and information:

http://web.mit.edu/sktech/download/pdf/skoltech-biomed-2014.pdf

https://www.regonline.com/builder/site/Default.aspx?EventID=1516613

 

 

Contact information:
Skoltech Communications
+7 (495) 280 14 81

Share on VK